UK drug chiefs issue alert on ANOTHER frightening risk of weight loss jabs - drugs raise risk of people choking to death
The Medicines and Healthcare Products Regulatory Agency (MHRA) has ruled that warnings about the risk should now be added to ...
About Half Of Americans Approve Of Using Weight-Loss Drugs To Treat Obesity, Ap-Norc Poll Finds
A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think about weight-loss drugs like Ozempic or Wegovy. (AP Video: Laura Bargfeld) ...
How to manage ‘food noise’ without drugs like Ozempic, according to a weight loss doc
Is food your focus? Food noise is a formidable foe for those looking to lose weight. It refers to intrusive, obsessive ...
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
HealthDay on MSN15h
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...
From anti-vaccine advocacy to raw milk, many of RFK Jr.’s views fall outside the mainstream
WASHINGTON (AP) — Robert F. Kennedy Jr.’s anti-vaccine advocacy is outside the mainstream. His previous statements on ...
Losing weight saved me $11K in one year — here’s how I did it
Less piggy, more bank. New year, new diet resolutions — and in 2025 more than ever, as Americans rush to sign up not just for ...
The truth about alcohol and your health, according to data
Northwell Health partnered with Stacker to examine data from the CDC, Pew, and other sources to compile research on alcohol ...
The surprising points of life where you're most vulnerable to ageing - and the very simple steps that can help you stay young
Whereas the previous thinking was that ageing is a linear, gradual process, recent research suggests that it in fact hits you ...
Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.